Brown, Lisle/Cummings’s Viatris VTRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.7K Hold
800
﹤0.01% 578
2026
Q1
$10.8K Hold
800
﹤0.01% 560
2025
Q4
$9.96K Hold
800
﹤0.01% 503
2025
Q3
$7.92K Sell
800
-24
-3% -$234 ﹤0.01% 526
2025
Q2
$7.36K Buy
824
+24
+3% +$203 ﹤0.01% 530
2025
Q1
$6.97K Hold
800
﹤0.01% 529
2024
Q4
$9.96K Sell
800
-1,079
-57% -$13.3K ﹤0.01% 484
2024
Q3
$21.8K Buy
1,879
+696
+59% +$8.03K 0.01% 389
2024
Q2
$12.6K Sell
1,183
-1,850
-61% -$20.4K ﹤0.01% 427
2024
Q1
$36.2K Buy
3,033
+982
+48% +$11.8K 0.01% 321
2023
Q4
$22.2K Sell
2,051
-3,421
-63% -$32.8K 0.01% 355
2023
Q3
$54K Sell
5,472
-4,688
-46% -$48.8K 0.02% 265
2023
Q2
$101K Sell
10,160
-1,000
-9% -$9.55K 0.05% 224
2023
Q1
$107K Sell
11,160
-1,000
-8% -$11.1K 0.05% 212
2022
Q4
$135K Buy
12,160
+290
+2% +$3.03K 0.07% 190
2022
Q3
$101K Sell
11,870
-756
-6% -$7.44K 0.06% 204
2022
Q2
$132K Sell
12,626
-2,526
-17% -$27.7K 0.07% 191
2022
Q1
$165K Buy
15,152
+3,262
+27% +$43K 0.08% 182
2021
Q4
$161K Buy
+11,890
New +$159K 0.08% 177

Other funds holding VTRS

Brown, Lisle/Cummings's VTRS Position: Q2 2026 in Review

Brown, Lisle/Cummings held its Viatris (VTRS) position steady in Q2 2026 at 800 shares worth $12.7K. The position accounts for ﹤0.01% of the portfolio, ranked #578.

Brown, Lisle/Cummings first reported a position in VTRS in Q4 2021 and has held it in 19 quarters since. The position peaked at $165K in Q1 2022. 1,028 funds tracked by Wall St. Rank hold VTRS as of Q2 2026.

  • Brown, Lisle/Cummings held 800 shares of Viatris worth $12.7K as of Q2 2026.
  • Brown, Lisle/Cummings left its Viatris share count unchanged in Q2 2026.
  • Viatris made up ﹤0.01% of Brown, Lisle/Cummings's portfolio in Q2 2026, its #578 holding.
  • Brown, Lisle/Cummings first reported a position in Viatris in Q4 2021 and has held it in 19 quarters since.
  • Brown, Lisle/Cummings's Viatris position peaked at $165K in Q1 2022.
  • 1,028 funds tracked by Wall St. Rank held Viatris as of Q2 2026.

Based on Brown, Lisle/Cummings's 13F filing for Q2 2026, filed 2 Sep 2026.